Jeffrey M. Kallemeyn

New Semi-Automated Computer-Based System for Assessing the Purge of Mutagenic Impurities

Martin A. Ott, Andrew Teasdale, Michael J. Burns, 2019, Organic Process Research & Development.

The Delivery of Flexibility from the Application of QbD to API Development

Jeffrey M. Kallemeyn, Sushil K. Srivastava, Kevin D. Seibert, 2018, Journal of Pharmaceutical Innovation.

Enhanced Approaches to the Identification, Evaluation, and Control of Impurities

Jeffrey M. Kallemeyn, Matt E. Popkin, Phil J. Borman, 2018, Journal of Pharmaceutical Innovation.

A consortium‐driven framework to guide the implementation of ICH M7 Option 4 control strategies

Dirk Lauwers, Chris Barber, Andrew Teasdale, 2017, Regulatory toxicology and pharmacology : RTP.

Development of the Enabling Route for Glecaprevir via Ring-Closing Metathesis

David R. Hill, Jeffrey M. Kallemeyn, Shuang Chen, 2020 .

The Development of Continuous Process for Alkene Ozonolysis Based on Combined in Situ FTIR, Calorimetry, and Computational Chemistry

Jeffrey M. Kallemeyn, Ayman D. Allian, S. Richter, 2011 .

A Kinetics-Based Approach for the Assignment of Reactivity Purge Factors

Jeffrey M. Kallemeyn, Dennie S. Welch, Rick C. Betori, 2015 .